Liver function may change how brain drug works
NCT ID NCT05731895
First seen Apr 03, 2026 · Last updated Apr 28, 2026 · Updated 6 times
Summary
This study looked at how the experimental brain drug iclepertin is processed in people with mild to moderate liver problems compared to those with healthy livers. 29 adults took a single tablet, and researchers measured drug levels in the blood. The goal was to see if liver impairment changes drug exposure, helping guide future dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC INSUFFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRS Clinical Research Services Kiel GmbH
Kiel, 24105, Germany
Conditions
Explore the condition pages connected to this study.